Pregabalin structure
|
Common Name | Pregabalin | ||
---|---|---|---|---|
CAS Number | 148553-50-8 | Molecular Weight | 159.226 | |
Density | 1.0±0.1 g/cm3 | Boiling Point | 274.0±23.0 °C at 760 mmHg | |
Molecular Formula | C8H17NO2 | Melting Point | 194-196ºC | |
MSDS | Chinese USA | Flash Point | 119.5±22.6 °C | |
Symbol |
GHS05, GHS08 |
Signal Word | Danger |
Name | Pregabalin |
---|---|
Synonym | More Synonyms |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 274.0±23.0 °C at 760 mmHg |
Melting Point | 194-196ºC |
Molecular Formula | C8H17NO2 |
Molecular Weight | 159.226 |
Flash Point | 119.5±22.6 °C |
Exact Mass | 159.125931 |
PSA | 63.32000 |
LogP | 1.12 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.465 |
Storage condition | Store at RT |
Symbol |
GHS05, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H318-H361 |
Precautionary Statements | P280-P305 + P351 + P338 |
Hazard Codes | Xn,T,F |
Risk Phrases | 63-48/22-39/23/24/25-23/24/25-11 |
Safety Phrases | 22-36/37-45-16-7 |
RIDADR | NONH for all modes of transport |
HS Code | 2915900090 |
HS Code | 2922499990 |
---|---|
Summary | HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0% |
Development of a SPE-HPLC-MS/MS method for the determination of most prescribed pharmaceuticals and related metabolites in urban sewage samples.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 990 , 23-30, (2015) Based on regional prescription data several pharmaceuticals with variable amounts of prescription and corresponding metabolites were selected and analyzed in influent and effluent samples of the sewag... |
|
Effect of the gastrointestinal prokinetic agent erythromycin on the pharmacokinetics of pregabalin controlled-release in healthy individuals: a phase I, randomized crossover trial.
Clin. Drug Investig. 35(5) , 299-305, (2015) The controlled-release (CR) formulation of pregabalin is designed to remain in the stomach for a prolonged period while slowly releasing pregabalin for absorption in the small intestine. This study ev... |
|
Evaluation of the matrix effect of different sample matrices for 33 pharmaceuticals by post-column infusion.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 1000 , 84-94, (2015) Matrix effects that occur during quantitative measurement by liquid chromatography mass spectrometry specifically when using electrospray ionization are a widely recognized phenomenon. Sample matrix c... |
(S)-3-Aminomethyl-5-methyl-hexanoic acid |
EINECS 200-659-6 |
(S)-3-(Aminomethyl)-5-methylhexanoic acid CI-1008 PD-144723 |
PREDNISOLONESODIUMPHOSPHATE |
Hexanoic acid, 3-(aminomethyl)-5-methyl-, (3S)- |
Pregablin |
(S)-3-(Aminomethyl)-5-methylhexanoic acid |
Pregabalin |
Lyrica |
prégabaline |
(S)-3-Isobutyl GABA |
MFCD00917044 |
(S)-(+)-3-aminomethyl-5-methylhexanoic acid |
(3S)-3-(Aminomethyl)-5-methylhexanoic acid |